Three decades of malignant pleural mesothelioma: an academic center experience

A Nasser, A Baird, MD Saint-Pierre, K Amjadi… - Clinical Lung Cancer, 2021 - Elsevier
Background Malignant pleural mesothelioma (MPM) remains a challenging disease to
manage. In the past few decades, extrapleural pneumonectomy (EPP), pemetrexed-based …

Three Decades of Malignant Pleural Mesothelioma: An Academic Center Experience

A Nasser, A Baird, MD Saint-Pierre… - Clinical Lung …, 2021 - clinical-lung-cancer.com
Background Malignant pleural mesothelioma (MPM) remains a challenging disease to
manage. In the past few decades, extrapleural pneumonectomy (EPP), pemetrexed-based …

Three Decades of Malignant Pleural Mesothelioma: An Academic Center Experience

A Nasser, A Baird, MD Saint-Pierre… - Clinical lung …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Malignant pleural mesothelioma (MPM) remains a challenging disease to
manage. In the past few decades, extrapleural pneumonectomy (EPP), pemetrexed-based …

Three Decades of Malignant Pleural Mesothelioma: An Academic Center Experience.

A Nasser, A Baird, MD Saint-Pierre, K Amjadi… - Clinical Lung …, 2021 - europepmc.org
Background Malignant pleural mesothelioma (MPM) remains a challenging disease to
manage. In the past few decades, extrapleural pneumonectomy (EPP), pemetrexed-based …